345 results on '"Woodman, Richard C."'
Search Results
2. Nilotinib 300 mg BID as frontline treatment of CML: Prospective analysis of the Xpert BCR-ABL Monitor system and significance of 3-month molecular response
3. Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib
4. Proinflammatory state, hepcidin, and anemia in older persons
5. The Elusive Oxidase The Respiratory Burst Oxidase of Human Phagocytes
6. Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia
7. Anaemia and the Risk of Injurious Falls in a Community-Dwelling Elderly Population
8. An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy
9. An Extended Dosing Regimen of Epoetin Alfa 60,000 Units Every 2 Weeks in Anemic Patients with Cancer Receiving Chemotherapy
10. Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy
11. Anemia in old age is associated with increased mortality and hospitalization
12. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the women's health and aging studies I and II
13. P38 MAPK: critical molecule in thrombin-induced NF-[kappa]B-dependent leukocyte recruitment
14. Anemia, Physical Disability, and Survival in Older Patients With Heart Failure
15. Anemia in the elderly: Current understanding and emerging concepts
16. Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation
17. Genomic Profiling in Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) Following HMA Failure: Baseline Results from the Inspire Study (04-30)
18. Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
19. The Inspire Study in Higher-Risk Myelodysplastic Syndrome (HR-MDS): A Novel Phase 3 Study Adaptive Design for Hematological Malignancies in Adults
20. Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults
21. Anemia and Recovery from Disability in Activities of Daily Living in Hospitalized Older Persons
22. The absence of anti-neutrophil cytoplasmic antibodies in patients with Henoch-Schönlein purpura
23. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia
24. Renal Function, Erythropoietin, and Anemia of Older Persons: The InCHIANTI Study
25. Greater area under the hemoglobin change curve is associated with improved outcomes in patients receiving epoetin alfa (EPO) or darbepoetin alfa (DARB) for chemotherapy-related anemia (CRA).: 234.
26. Anemia Is Associated with Disability and Decreased Physical Performance and Muscle Strength in the Elderly
27. Excess nitric oxide does not cause cellular, vascular, or mucosal dysfunction in the cat small intestine
28. Nitric oxide prevents leukocyte adherence: role of superoxide
29. Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1
30. The Functional Paradox of CD43 in Leukocyte Recruitment: A Study Using CD43-deficient Mice
31. Large granular lymphocyte leukaemia occurring after renal transplantation
32. Modulation of neutrophil function by the tripeptide feG
33. Identification of the soluble granulocyte-macrophage colony stimulating factor receptor protein in vivo
34. Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience
35. Infection with "Pseudomonas cepacia" in Chronic Granulomatous Disease: Role of Nonoxidative Killing by Neutrophils in Host Defense
36. Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease
37. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis in a patient with Down's syndrome
38. Selective recruitment of neutrophils and lymphocytes by thrombin: a role for NF-[Kappa]
39. Thrombin and leukocyte recruitment in endotoxemia
40. Translational inhibition of E-selectin expression stimulates P-selectin-dependent neutrophil recruitment
41. Meaningful change and responsiveness in common physical performance measures in older adults
42. The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours
43. Efficacy of Nilotinib Vs High-Dose Imatinib Vs Sustaining Standard-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Response to Frontline Imatinib
44. Efficacy of Treatments in Relapsed or Relapsed and Refractory Multiple Myeloma: An Indirect Treatment Comparison
45. Anemia and cancer in older persons
46. ENESTxtnd: Impact Of Nilotinib Dose Re-Escalation In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)
47. Nilotinib Or High-Dose Imatinib Compared With Standard-Dose Imatinib In Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses To Standard-Dose Imatinib: Including Updated Data From RE-Nice Study
48. MDR1 Gene Expression Predicts Response and Progression-Free Survival Of Ph+ CML Patients On Second-Line Nilotinib Therapy After Imatinib Failure - 4-Year Follow-Up
49. Modulation of neutrophil function by the tripeptide feG
50. Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.